Table 1 Characteristics of the patient population (N = 100)

Number

100

73

27

80

20

57

43

Women/men (n)

73/27

na

na

66/14

7/13**

40/17

33/10***

Caucasian ethnicity (n)

97

94

27

79

18

55

42

Age (years)

68 ± 10

70 ± 9

62 ± 8*

69,1 ± 9

63.3 ± 9**

71 ± 10

64 ± 7***

Weight (kg)

66 ± 13

63 ± 13

73 ± 11*

65,4 ± 14

68.8 ± 11

64 ± 14

69 ± 11

Spine T-score

-2.88 ± .91

-2.94 ± 0.79

-2.73 ± 1.17

-2.9 ± 0.92

-2.8 ± 0.83

-2.85 ± 0.97

-2.93 ± 0.82

Hip T-score

-1.92 ± 0.9

-2.13 ± 0.92

-1.37 ± 0.70*

-2 ± 0.87

-1.6 ± 1.09

-2.1 ± 1.00

-0.66 ± 0.63***

Hip Z-score

-1.92 ± 0.8

-0.57 ± 0.85

-0.89 ± 0.73

-0.62 ± 0.85

-0.83 ± 0.72

-0.66 ± 0.97

-0.66 ± 0.63

BMD spine(g/sq cm)

0.772+/- 0.100

0.756 ± 0.085

0.810 ± 0.130*

0.765 ± 0.103

0.795 ± 0.094

0.776 ± 0.109

0.766 ± 0.091

BMD hip(g/sq cm)

0.718+/- 0.395

0.676 ± 0.115

0.825 ± 0.107*

0.700 ± 0.116

0.779 ± 0.160**

0.695 ± 0.143

0.749 ± 0.106

Calcium intake(mg/day)

852 ± 432

828 ± 448

915 ± 389

851 ± 467

854 ± 266

744 ± 343

993 ± 497***

Serum 25OH vitamin D (nmol/L)

66 ± 53

67 ± 60

63 ± 28

63 ± 57

75 ± 30

42

0

Creatinine clearance (ml/min)

67 ± 23

62 ± 20

65 ± 23

65 ± 23

74 ± 26

45 ± 18

82 ± 24***

Fracture after fall from standing height (n)

80

66

14

na

na

45

35

N of contributors (n)

86

62

24

70

16

na

na

N with contributors (n)

57

40

17

45

12

na

na

N with bone-related fracture risks

54

42

12

44

10

33

21

N with fall-related fracture risks

79

57

22

65

14

46

33

Time Go Up and Go (min)

8.6 ± 7.9

8.4 ± 8.0

8.9 ± 8.0

8.2 ± 8.0

9.8+/-8.0

8.1+/-8.6

9.2+/-7.1

N with MVD <0.80 (n/n measured)

53/93

35/66

18/27

42/73

11/20

36/54

17/39***

N with MVD <0.75

29

22

7

24

11

19

10